Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia-Reference-Cited by-同舟云学术

Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia

Published:2010-06 Issue:6 Volume:51 Page:1524-1534
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Sundaram Meenakshi,Zhong Shumei,Khalil Maroun Bou,Zhou Hu,Jiang Zhenghui G.,Zhao Yang,Iqbal Jahangir,Hussain M. Mahmood,Figeys Daniel,Wang Yuwei,Yao Zemin

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference46 articles.

1. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3;Jong;Arterioscler. Thromb. Vasc. Biol.,1999

2. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions;Fredenrich;J. Lipid Res.,1997

3. Apolipoprotein C–II and C–III levels in hyperlipoproteinemia;Schonfeld;Metabolism.,1979

4. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection;Pollin;Science.,2008

5. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles;Aalto-Setala;J. Clin. Invest.,1992

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FoxO6-mediated ApoC3 upregulation promotes hepatic steatosis and hyperlipidemia in aged rats fed a high-fat diet;Aging;2024-03-03

2. ApoCIII: A multifaceted protein in cardiometabolic disease;Metabolism;2020-12

3. ApoC-III helical structure determines its ability to bind plasma lipoproteins and inhibit Lipoprotein Lipase-mediated triglyceride lipolysis;2020-07-03

4. Recent developments in pharmacotherapy for hypertriglyceridemia: what’s the current state of the art?;Expert Opinion on Pharmacotherapy;2019-11-18

5. Harnessing nucleic acid-based therapeutics for atherosclerotic cardiovascular disease: state of the art;Drug Discovery Today;2019-05